Related Experiment Video
Updated: May 24, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Cardiac biomarkers in acute myocardial infarction
1Christchurch Hospital, Christchurch, New Zealand. sally.aldous@cdhb.govt.nz
Insights
Cardiac troponin is the gold standard for diagnosing myocardial infarction, offering high accuracy. While other biomarkers exist, none surpass troponin
Area of Science:
- Cardiology
- Biomarker Research
Background:
- Emergency departments frequently evaluate patients for acute myocardial infarction.
- Cardiac biomarkers play a crucial role in diagnosing and predicting outcomes for myocardial infarction.
- Current diagnostic methods include symptoms, risk factors, and electrocardiogram results.
Purpose of the Study:
- To review the historical development and current status of cardiac biomarkers for myocardial infarction.
- To evaluate the diagnostic and prognostic utility of various cardiac biomarkers.
Main Methods:
- Review of established and novel cardiac biomarker assays.
- Analysis of existing literature on biomarker performance in myocardial infarction diagnosis and prognosis.
Main Results:
- Cardiac troponin is the current gold standard, demonstrating high sensitivity and specificity for myocardial infarction.
- Elevated troponin levels are linked to outcomes, and therapies can influence these.
- Other biomarkers (necrosis, inflammation, neurohormonal) show utility but are not superior to troponin.
Conclusions:
- Cardiac troponin remains the most effective biomarker for acute myocardial infarction diagnosis.
- Investigating multiple biomarkers and point-of-care testing may enhance diagnostic efficiency.
Abstract:
Each year, a large number of patients are seen in the Emergency Department with presentations necessitating investigation for possible acute myocardial infarction. Patients can be stratified by symptoms, risk factors and electrocardiogram results but cardiac biomarkers also have a prime role both diagnostically and prognostically. This review summarizes both the history of cardiac biomarkers as well as currently available (established and novel) assays. Cardiac troponin, our current "gold standard" biomarker criterion for the diagnosis of myocardial infarction has high sensitivity and specificity for this diagnosis and therapies instituted in patients with elevated troponin have been shown to influence outcomes. Other markers of myocardial necrosis, inflammation and neurohormonal activity have also been shown to have either diagnostic or prognostic utility, but none have been shown to be superior to troponin. The measurement of multiple biomarkers and the use of point of care markers may accelerate current diagnostic protocols for the assessment of such patients.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests